KORU Medical Systems: Horton receives 5,119 shares

The award was attributed to the fund’s indirect holdings, alongside a separately reported direct position of 782,547 shares.

Rhea-AI Filing Summary

KORU Medical Systems, Inc. reported that Horton Capital Partners Fund, L.P. acquired 5,119 common shares as a grant/award on September 30, 2026, with a reported price of $0 per share. The fund’s reported indirect holdings after the award were 5,074,660 shares. The reporting persons were Joseph M. Manko Jr. (director and 10% owner), Horton Capital Management, LLC, Horton Capital Partners, LLC, and Horton Capital Partners Fund, L.P. (each identified as a 10% owner). Separately, 782,547 shares were listed as directly held as of September 30, 2026.

Insider Trade Summary

Grant/Award: 5,119 shares

Grant/Award 2 txns

Insider Manko Joseph M. Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, Horton Capital Partners Fund, L.P.

Role Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	5,119	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 5,074,660 shares (Indirect, By Horton Capital Partners Fund, LP); Common Stock — 782,547 shares (Direct)

Footnotes (2)

1. F1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
2. F2. See Exhibit 99.1 to this Form 4 for explanation of note (2).

Key Figures

Common shares acquired as a grant/award: 5,119 shares Reported price per share: $0 per share Indirect shares held after award: 5,074,660 shares +1 more

4 metrics

Common shares acquired as a grant/award 5,119 shares September 30, 2026

Reported price per share $0 per share Grant/award on September 30, 2026

Indirect shares held after award 5,074,660 shares Horton Capital Partners Fund, L.P.

Direct shares held 782,547 shares As of September 30, 2026

Key Terms

beneficial owner, Section 16, equity securities

3 terms

beneficial owner regulatory

"beneficial owner of any equity securities"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

Section 16 regulatory

"for the purposes of Section 16 of the Securities Exchange Act of 1934"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

equity securities financial

"beneficial owner of any equity securities covered by this statement"

Equity securities are financial instruments that represent ownership shares in a company, like owning a slice of a pie that gives you a claim on its assets and future profits. They matter to investors because ownership can provide returns through price appreciation and occasional profit distributions, and may include voting power to influence company decisions, so their value reflects the firm’s performance and investor expectations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KRMD shares did Horton Capital Partners Fund, L.P. acquire?

Horton Capital Partners Fund, L.P. acquired 5,119 KORU Medical Systems common shares as a grant/award on September 30, 2026, with a reported price of $0 per share. Its reported indirect holdings after the transaction were 5,074,660 shares.

How many KRMD shares were reported as directly held?

Direct holdings were 782,547 shares as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 07:22 PM Accepted by SEC EDGAR 10/01/2026 - 07:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Manko Joseph M. Jr.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2026		A		5,119	A	$0(1)	5,074,660	I	By Horton Capital Partners Fund, LP(2)
Common Stock								782,547	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Manko Joseph M. Jr.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Management, LLC

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Partners, LLC

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Horton Capital Partners Fund, L.P.

(Last) (First) (Middle)

1717 ARCH STREET

37TH FLOOR

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. See Exhibit 99.1 to this Form 4 for explanation of note (1).

2. See Exhibit 99.1 to this Form 4 for explanation of note (2).

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.

	/s/ Joseph M. Manko, Jr.	10/01/2026
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC	10/01/2026
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC	10/01/2026
	/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)